loader

graft versus host disease

LATEST ARTICLES
OTC:KALTF
cannabis investing

Kalytera Reports Data for First Cohort in Phase 2 Clinical Study Evaluating CBD in Prevention of Acute GVHD

OTC:KALTF
cannabis investing

Kalytera Announces Initiation of Study KAL-07 – Food Effect Study

TSXV:KALY
cannabis investing

Kalytera Announces Share Issuance for January Invoices under Payments Agreements with Salzman Group

OTCQB:KALTF
cannabis investing

Kalytera Reports Additional Positive Data for CBD in Prevention of Acute GVHD

OTCQB:KALTF
cannabis investing

Kalytera Announces Change to Scope of Services under Payments Agreements with Salzman Group and Next Share Issuance

OTCQB:KALTF
cannabis investing

Kalytera Announces Closing of Private Placement of Common Shares and Common Share Purchase Warrants

OTCQB:KALTF
cannabis investing

Kalytera Announces Closing of Private Placement of Common Shares and Common Share Purchase Warrants

OTCQB:KALTF
cannabis investing

Kalytera Announces Share Issuance and Extension to March 1 under Payments Agreements with Salzman Group

OTCQB:KALTF
cannabis investing

Kalytera Announces Private Placement of Common Shares and Common Share Purchase Warrants

OTCQB:KALTF

Kalytera Provides Update on Phase 2 Clinical Study Evaluating CBD in Prevention of Acute GVHD

Biotech Investing

Big News Roundup: Kalytera Announces Issuance of Second Patent Covering the Use of CBD in Graft Versus Host Disease; Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis

Genetics Investing

Cynata Therapeutics Receives Orphan Drug Designation from FDA

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES